-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Candel Therapeutics Inc. (CADL)
-
-
-
-
-
-
-
Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
-
-
-
-
-
-
Candel Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
-
-
-
-
-
-
-
Candel Therapeutics to Present at Two Upcoming Investor Conferences
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

